Kara, FadilKiran, GuerkanMetindir, JaleOzan, HakanOzalp, SinanVardar, M. AliSam, Asli Demir2025-05-102025-05-1020090020-72921879-347910.1016/j.ijgo.2009.04.0032-s2.0-68349139717https://doi.org/10.1016/j.ijgo.2009.04.003https://hdl.handle.net/20.500.14720/9923Kocak, Cengiz/0000-0003-3819-6822; Guven, Suleyman/0000-0003-4832-4525; Karaca, Mehmet/0000-0003-3219-9109; Mutlu, Ahmet Emin/0000-0002-5092-1364; Kiran, Gurkan/0000-0002-6300-328XObjective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.eninfo:eu-repo/semantics/closedAccessCervical CancerCervical CytologyCervical Intraepithelial NeoplasiasCervical NeoplasiasPap TestPap SmearTurkeyArticle1063Q2Q120620919541303WOS:000269782800005